Cargando…
Corporate immunity to the COVID-19 pandemic
We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, l...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457922/ https://www.ncbi.nlm.nih.gov/pubmed/34580557 http://dx.doi.org/10.1016/j.jfineco.2021.03.005 |
_version_ | 1784571209393897472 |
---|---|
author | Ding, Wenzhi Levine, Ross Lin, Chen Xie, Wensi |
author_facet | Ding, Wenzhi Levine, Ross Lin, Chen Xie, Wensi |
author_sort | Ding, Wenzhi |
collection | PubMed |
description | We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, less total and short-term debt, and larger profits), less exposure to COVID-19 through global supply chains and customer locations, more corporate social responsibility activities, and less entrenched executives. Furthermore, the stock returns of firms controlled by families (especially through direct holdings and with non-family managers), large corporations, and governments performed better, and those with greater ownership by hedge funds and other asset management companies performed worse. Stock markets positively price small amounts of managerial ownership but negatively price high levels of managerial ownership during the pandemic. |
format | Online Article Text |
id | pubmed-8457922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84579222021-09-23 Corporate immunity to the COVID-19 pandemic Ding, Wenzhi Levine, Ross Lin, Chen Xie, Wensi J financ econ Article We evaluate the connection between corporate characteristics and the reaction of stock returns to COVID-19 cases using data on more than 6,700 firms across 61 economies. The pandemic-induced drop in stock returns was milder among firms with stronger pre-2020 finances (more cash and undrawn credit, less total and short-term debt, and larger profits), less exposure to COVID-19 through global supply chains and customer locations, more corporate social responsibility activities, and less entrenched executives. Furthermore, the stock returns of firms controlled by families (especially through direct holdings and with non-family managers), large corporations, and governments performed better, and those with greater ownership by hedge funds and other asset management companies performed worse. Stock markets positively price small amounts of managerial ownership but negatively price high levels of managerial ownership during the pandemic. Elsevier B.V. 2021-08 2021-03-07 /pmc/articles/PMC8457922/ /pubmed/34580557 http://dx.doi.org/10.1016/j.jfineco.2021.03.005 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ding, Wenzhi Levine, Ross Lin, Chen Xie, Wensi Corporate immunity to the COVID-19 pandemic |
title | Corporate immunity to the COVID-19 pandemic |
title_full | Corporate immunity to the COVID-19 pandemic |
title_fullStr | Corporate immunity to the COVID-19 pandemic |
title_full_unstemmed | Corporate immunity to the COVID-19 pandemic |
title_short | Corporate immunity to the COVID-19 pandemic |
title_sort | corporate immunity to the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457922/ https://www.ncbi.nlm.nih.gov/pubmed/34580557 http://dx.doi.org/10.1016/j.jfineco.2021.03.005 |
work_keys_str_mv | AT dingwenzhi corporateimmunitytothecovid19pandemic AT levineross corporateimmunitytothecovid19pandemic AT linchen corporateimmunitytothecovid19pandemic AT xiewensi corporateimmunitytothecovid19pandemic |